Main > UROLOGY > Over Active Bladder (InContinence) > Treatment > Darifenacin > Co.: CH. N. (Brand ER Tab./Patents)

---

Co.: CH. N. (Brand ER Tab./Patents)'s subsections
Company
Muscarinic Receptor AntAgonist
Partner
Patent>DisClosure
Patent>Formulation
Patent>Hydrate
Patent>Total USA No.: 4
Patent>UpDate: 01.15.08
Patent>USA Expiration: 03.13.2015
Systematic (IUPAC) Name
TradeMark
Web-Site

Co.: CH. N. (Brand ER Tab./Patents)'s products
This section has no products